Surface Oncology, Inc.
SURFDelisted Sep 8, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001718108
Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Surface Oncology, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −3 vs. Q4 2021
- Shares held
- 31.9M
- +7.24M (+29.3%) vs. Q4 2021
- Total value
- $93.8M
- −$24.2M (−20.5%) vs. Q4 2021
- New holders
- 20
- 32 more added
- Sold out
- 23
- 32 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SURF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $21.0K |
| Q3 2025 | 1 | $21.0K |
| Q2 2025 | 1 | $21.0K |
| Q1 2025 | 1 | $21.0K |
| Q4 2024 | 1 | $21.0K |
| Q3 2024 | 1 | $21.0K |
| Q2 2024 | 1 | $21.0K |
| Q1 2024 | 1 | $21.0K |
| Q4 2023 | 1 | $21.0K |
| Q3 2023 | 2 | $21.3K |
| Q2 2023 | 62 | $16.9M |
| Q1 2023 | 72 | $18.8M |
| Q4 2022 | 80 | $23.4M |
| Q3 2022 | 80 | $32.8M |
| Q2 2022 | 85 | $48.6M |
| Q1 2022 | 104 | $93.8M |
| Q4 2021 | 107 | $118.0M |
| Q3 2021 | 92 | $182.2M |
| Q2 2021 | 97 | $168.5M |
| Q1 2021 | 91 | $147.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Surface Oncology, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 4,653,000 | $13.7M | 0.43% | +4,653,000 | New |
| ARK Investment Management LLCSuperinvestorARK Invest | 5,343,116 | $15.7M | 0.07% | +16,989+0.3% | Added |
| Advisor Group Holdings, Inc. | 11,466 | – | – | −900−7.3% | Reduced |
| IFP Advisors, Inc | 1,585 | – | – | +1,585 | New |
| Proequities, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −520,021−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −467,945−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −328,228−100.0% | Sold out |
| Goldstream Capital Management Ltd | 0 | $0 | 0.00% | −241,285−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −133,500−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −38,300−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −32,603−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −29,459−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −28,800−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −25,371−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,192−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −18,393−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,085−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,312−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −11,966−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −5,860−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Edge Wealth Management LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |